Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 200,000,000
    Countries
    Sector(s)
    France : € 200,000,000
    Credit lines : € 200,000,000
    Signature date(s)
    7/10/2021 : € 200,000,000

    Summary sheet

    Release date
    25 March 2021
    Status
    Reference
    Signed | 07/10/2021
    20210002
    Project name
    Promoter - financial intermediary
    LCL SOUTIEN ZONES MEDICALES EN TENSION MBIL
    CREDIT LYONNAIS
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 200 million
    not applicable
    Location
    Sector(s)
    Description
    Objectives

    The operation is a EUR 200 million multiple beneficiary intermediated loan (MBIL) which aims at facilitating access to long-term finance for projects carried out by professionals/small and medium-sized enterprises (SMEs) active in the healthcare and pharmaceutical sectors in France with a specific 20% window dedicated to regions where access to medical experts is sub-optimal/underserved.

    Financing of small/medium projects carried out by professionals and SMEs active in the healthcare and pharmaceutical sector in France.

    Additionality and Impact

    The facility aims at supporting investments made by professionals and SMEs active in the healthcare sector in France with a specific focus on underserved regions.

    EIB intervention will enable to improve the competition between FIs active on this market and will improve funding conditions for healthcare professionals (pricing decrease is contractually stated). In addition, through its specific focus on underserved regions, the proposed operation is expected to support professional willing to settle down in these regions where access to medical offer is limited and hence improve citizen's access to medical professional across the territory.

    Environmental aspects
    Procurement

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.

    Link to source

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications